ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,799Medicare Part D Prescriptions Filled, Including Refills

Rank: 438 out of 5176

$733K Total Retail Price of All Prescriptions

Rank: 560 out of 5176

308 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 308 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 308 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,522 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LISINOPRIL 474 407 1 5
WARFARIN SODIUM 461 360 2 13
CITALOPRAM HBR 451 413 3 31
LEVOTHYROXINE SODIUM 443 430 4 4
FUROSEMIDE 426 412 5 8
OMEPRAZOLE 379 357 6 3
DONEPEZIL HCL 334 321 7 28
SIMVASTATIN 325 313 8 1
METOPROLOL TARTRATE 285 271 9 6
MIRTAZAPINE 217 216 10 45
METOPROLOL SUCCINATE 201 201 11 11
SERTRALINE HCL 194 166 12 30
QUETIAPINE FUMARATE 183 182 13 75
TRAZODONE HCL 181 181 14 71
GABAPENTIN 174 146 15 21
NAMENDA 172 159 16 47
LANTUS 171 127 17 66
ATENOLOL 162 149 18 12
RISPERIDONE 160 138 19 78
ATORVASTATIN CALCIUM 150 142 20 9
NOVOLIN R 118 90 21 191
SPIRONOLACTONE 114 112 22 88
AMLODIPINE BESYLATE 112 111 23 2
PANTOPRAZOLE SODIUM 110 110 24 61
ESCITALOPRAM OXALATE 109 109 25 89
LEVETIRACETAM 109 77 25 92
CARBIDOPA-LEVODOPA 107 94 27 98
NYSTOP 106 101 28 283
METFORMIN HCL 102 76 29 7
VENLAFAXINE HCL ER 101 101 30 186
NOVOLOG 100 61 31 168
LEVOFLOXACIN 97 76 32 109
SPIRIVA 95 83 33 54
CYMBALTA 93 77 34 90
BACLOFEN 91 51 35 173
EXELON 91 91 35 162
PAROXETINE HCL 89 61 37 93
HALOPERIDOL 79 66 38 145
FLUOXETINE HCL 74 74 39 132
CARVEDILOL 74 62 39 24
HYDROCODONE-ACETAMINOPHEN 71 66 S3 41 27
DILTIAZEM 24HR CD 70 68 42 119
SEROQUEL 70 68 42 166
VENLAFAXINE HCL 69 69 44 309
PREDNISONE 68 61 45 52
PRAVASTATIN SODIUM 68 44 45 23
ADVAIR DISKUS 64 62 47 32
NAPROXEN 60 33 48 95
TAMSULOSIN HCL 58 58 49 20
CEPHALEXIN 57 57 50 189
RESTASIS 53 53 51 353
AVELOX 53 52 51 352
AGGRENOX 51 51 53 235
SILVER SULFADIAZINE 51 51 53 207
CLOTRIMAZOLE-BETAMETHASONE 50 50 55 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.